Will be replaced by current CEO, John McDermott.
Symmetry's acquired technology gets a new look.
Company says death count is less than study shows.
Data continues to focus on effects to R&D and jobs.
Cathether system is designed for long-term vascular access.
Agreement broadens markets for both firms, gives AngioDynamics first shot at purchase.
Technology was acquired through Codman & Shurtleff purchase.
Guidewire system helps to determine severity of artery blockage.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.